Vitamin D supplementation in patients with alcoholic liver cirrhosis: a prospective study

Minerva Med. 2018 Oct;109(5):352-357. doi: 10.23736/S0026-4806.18.05723-3. Epub 2018 Jul 2.

Abstract

Background: The liver is involved in the metabolism of vitamin D. The prevalence of osteopenia in alcoholic liver disease (ALD) patients is 34-48%, and the prevalence of osteoporosis is 11-36%. Advanced liver disease is considered a risk factor for the development of osteoporosis. The aim of this study was to establish the relationship between vitamin D level and Child-Pugh score in patients with alcoholic liver cirrhosis (ALC), and to evaluate the effects of oral vitamin D supplementation.

Methods: Seventy male ALC patients in the absence of active alcohol intake were enrolled and their clinical and laboratory data were recorded. A supplementation of cholecalciferol 1000 IU/day was administered. The vitamin D status was analyzed during the study, in patients stratified by Child-Pugh score.

Results: The study was completed by fifty patients. At the enrollment, the mean level of vitamin D was 60.73±28.02, 50.53±39.52 and 26.71±12.81 nmol/L, respectively for Child-Pugh score class A, B and C. During vitamin D supplementation it was found in all the patients a significant increase of its levels during the first six months (P<0.05). However, in class C the improvement was consistent also after year (P<0.05). At the end of the study, two of seven patients initially in class C changed in class A, four from class C to B, and one remained in class C (P=0.012). Out of seventeen patients initially in class B, eleven changed to class A, and six remained in class B.

Conclusions: In patients with ALC, higher level of vitamin D level is related with lower Child-Pugh score. The supplementation of 1000 IU/day of vitamin D in these patients was optimal for a period of at least six months. A decrease in the Child-Pugh score was also found, with a redistribution of the patients in different classes.

Publication types

  • Clinical Trial

MeSH terms

  • Bilirubin / blood
  • Bone Diseases, Metabolic / etiology
  • Bone Diseases, Metabolic / prevention & control
  • Cholecalciferol / metabolism
  • Cholecalciferol / therapeutic use*
  • Dietary Supplements*
  • Humans
  • International Normalized Ratio
  • Liver Cirrhosis, Alcoholic / blood
  • Liver Cirrhosis, Alcoholic / complications*
  • Male
  • Middle Aged
  • Osteoporosis / etiology
  • Osteoporosis / prevention & control
  • Prospective Studies
  • Serum Albumin / analysis
  • Severity of Illness Index
  • Treatment Outcome
  • Vitamin D / blood*
  • Vitamin D Deficiency / blood
  • Vitamin D Deficiency / drug therapy*
  • Vitamin D Deficiency / etiology

Substances

  • Serum Albumin
  • Vitamin D
  • Cholecalciferol
  • Bilirubin